LAVA Therapeutics Provides Business Update and Reports First Quarter Financial Results
GlobeNewswire
May 20, 2021
IPO bolsters balance sheet to $160 million in cash and cash equivalents; expected to fund operations at least into the second half of 2023 UTRECHT, The Netherlands and PHILADELPHIA, May 20, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics...